0.5 ML benralizumab 20 MG/ML Prefilled Syringe

RxCUI: 2679499
RxNorm name: 0.5 ML benralizumab 20 MG/ML Prefilled Syringe
Display name: 0.5 ML benralizumab 20 MG/ML Prefilled Syringe
Full name: 0.5 ML benralizumab 20 MG/ML Prefilled Syringe
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761070	Fasenra	benralizumab	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
FASENRA	BENRALIZUMAB	AstraZeneca Pharmaceuticals LP	da6aca1a-19ed-44a4-abb7-696c7d58b784	2026-05-13	Warnings, Adverse reactions	Exact identifier rxcui: 2679499

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
da6aca1a-19ed-44a4-abb7-696c7d58b784	0.5 ML benralizumab 20 MG/ML Prefilled Syringe	SCD	27	These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017	20260513
da6aca1a-19ed-44a4-abb7-696c7d58b784	benralizumab 10 MG per 0.5 ML Prefilled Syringe	SY	27	These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017	20260513
da6aca1a-19ed-44a4-abb7-696c7d58b784	benralizumab 10 MG in 0.5 ML Prefilled Syringe	PSN	27	These highlights do not include all the information needed to use FASENRA ® safely and effectively. See full prescribing information for FASENRA. FASENRA (benralizumab) injection, for subcutaneous use Initial U.S. Approval: 2017	20260513